Translation. Region: Russian Federation –
Source: People's Republic of China in Russian – People's Republic of China in Russian –
An important disclaimer is at the bottom of this article.
Source: People's Republic of China – State Council News
Beijing, February 15 /Xinhua/ — According to a forecast by investment bank CEC Capital Group, China's biotechnology manufacturing market will grow to 1.8 trillion yuan by 2030, accounting for almost a quarter of the global market. This means China will become a key global force in this field.
The bioprocessing industry, which uses living organisms (cells, enzymes, etc.) for large-scale processing and synthesis of substances, spans numerous fields, including medicine, chemicals, materials production, and energy. China's active development of this cutting-edge sector is a key step in the country's strategic economic transition to innovation-driven, green, and sustainable development.
"In the next three to five years, driven by both technological innovation and policy incentives, the bioprocessing industry will enter a period of accelerated development," noted Cao Hui, an industry analyst at the Beijing University of Chemical Technology. "These transformations will change the face of traditional industry and profoundly impact our way of life and production."
This industry has become one of China's priority emerging industries of strategic importance. More than 20 provinces and cities across the country have already introduced specific support measures, including the creation of research funds and the construction of specialized industrial parks.
The integration of advanced biotechnology with industrial applications is yielding significant results. For example, at Shougang Group, a leading Chinese metallurgical company, carbon monoxide-rich industrial exhaust gases are no longer discharged directly but are instead piped into bioreactors. Specially bred microbial strains effectively convert them into single-cell proteins with a crude protein content of over 80%, turning waste into a valuable resource.
"If this technology is widely adopted, it will help reduce China's dependence on imported feed proteins such as soybeans," explained a project engineer at Shougang Group.
In healthcare, the combination of biotechnology and artificial intelligence (AI) is leading to revolutionary breakthroughs. Beijing-based Yimiao Donghe, using AI to analyze massive amounts of biomedical data, has reduced the time it takes to find potential drug targets against respiratory syncytial virus (RSV) by 80 percent compared to traditional methods. A vaccine candidate developed using this technology has already received approval from the US Food and Drug Administration (FDA) for clinical trials.
“AI can reduce the molecule discovery cycle from two years to approximately 11 months, while significantly reducing costs,” the company’s researchers note, adding that this is becoming a new competitive advantage for Chinese biopharmaceuticals on the global stage.
Beyond economic scale, the active use of biotechnology in China's industry is closely linked to sustainable development goals. Compared to traditional petrochemicals, bioprocessing typically uses renewable bio-based feedstocks and boasts higher energy efficiency and lower carbon emissions.
"Biotechnology-based manufacturing is environmentally friendly, uses renewable raw materials, and reduces energy consumption and emissions. It is becoming a strategic driver for shaping the competitiveness of Chinese industry of the future," emphasized Xu Guanhua, an academician at the Chinese Academy of Sciences (CAS).
"In the next three to five years, the biotechnology-based manufacturing industry will enter a phase of accelerated development. It will not only transform production methods in many traditional industries but also reshape many aspects of our lives and daily routines," says Cao Hui. According to forecasts, by 2050, the global bioprocessing industry could generate economic value of $30 trillion, accounting for a third of global industrial output.
As China continues to integrate its comprehensive strengths in biotechnology, industrial engineering, and digital technologies, its bioprocessing industry is not only growing in scale but also laying the foundation for a more innovative and sustainable economy in the future. This will have a profound impact on global value chains and the structure of the global bioeconomy.
Please note: This information is raw content obtained directly from the source. It represents an accurate account of the source's assertions and does not necessarily reflect the position of MIL-OSI or its clients.